Characterization of protective immunity induced against Schistosoma mansoni via DNA priming with the large subunit of calpain (Sm-p80) in the presence of genetic adjuvants
Despite advances in control via snail eradication and large-scale chemotherapy using praziquental, schistosomiasis continues to spread to new geographic areas particularly in sub-Saharan Africa. Presently, there is no vaccine for controlling this disease. We have concentrated on a functionally impor...
Main Authors: | Siddiqui A.A., Pinkston J.R., Quinlin M.L., Kavikondala V., Rewers-Felkins K.A., Phillips T., Pompa J. |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2005-03-01
|
Series: | Parasite |
Subjects: | |
Online Access: | http://dx.doi.org/10.1051/parasite/2005121003 |
Similar Items
-
Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection
by: Weidong Zhang, et al.
Published: (2020-06-01) -
Imatinib activity on Schistosoma mansoni
by: Naftale Katz, et al.
Published: (2013-11-01) -
Brain schistosomiasis in mice experimentally infected with Schistosoma mansoni
by: José Roberto Lambertucci, et al.
Published: (2014-05-01) -
Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine
by: Miriam Tendler, et al.
Published: (2018-11-01) -
Experimental models of Schistosoma mansoni infection
by: Cheever Allen W, et al.
Published: (2002-01-01)